What is Genesis Research?
Founded in 2009 and headquartered in Hoboken, New Jersey, Genesis Research operates as a specialized research organization dedicated to the life sciences industry. The firm provides essential HEOR and Real-World Evidence (RWE) services, enabling clients to navigate complex regulatory and market access environments. With a dual presence in the United States and the United Kingdom, the company serves as a strategic partner for organizations seeking to demonstrate the value of their therapeutic assets through rigorous data analysis and evidence-based research methodologies. Their market position is defined by a deep integration into the drug development lifecycle, ensuring that clinical efficacy is effectively translated into commercial and patient-centric value.
How much funding has Genesis Research raised?
Genesis Research has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Genesis Research
PPP
Public-Private Partnership
What's next for Genesis Research?
With the recent influx of capital, Genesis Research is well-positioned to accelerate its expansion into emerging therapeutic markets and enhance its proprietary data analytics capabilities. The firm is expected to focus on scaling its RWE infrastructure to meet the increasing demand for longitudinal patient data in the post-approval phase. As the life sciences sector shifts toward value-based care models, Genesis Research will likely prioritize the development of advanced digital health solutions and expanded global research footprints. This strategic growth phase will be instrumental in maintaining their competitive edge as a premier provider of evidence-based insights, ultimately driving better health outcomes and supporting the commercial viability of next-generation medical innovations.
See full Genesis Research company page
